Stocktoria
Fisher & Paykel Healthcare Corporation Limited FPH.NZ
Fisher & Paykel Healthcare Corporation Limited (FPH.NZ) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.10% (safety: moderate). FY2026 revenue was $2.3B at a 20.3% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 36 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.229 |
| Retained earnings / assets | 0.506 |
| EBIT / assets | 0.167 |
| Equity / liabilities | 2.866 |
FAQ
Is FPH.NZ financially healthy?
Fisher & Paykel Healthcare Corporation Limited's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does FPH.NZ pay a dividend, and is it safe?
Yes. Fisher & Paykel Healthcare Corporation Limited pays a dividend yielding about 1.10% with a 53.9% payout ratio, rated “moderate” for safety.
How profitable is FPH.NZ?
In FY2026, Fisher & Paykel Healthcare Corporation Limited had a net margin of 20.3% and a return on equity of 22.1%.
Source: company filings via Yahoo Finance · NZ · as of 2026-03-31. Figures in NZD; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.